ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Roche’s Hemlibra stakes claim to be haemophilia market leader
May 25, 2018Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements its prospects in the field. -
Trial findings back wider use of Roche’s Hemlibra
May 24, 2018Currently, the therapy is approved to treat those with the condition who have factor VIII inhibitors, that is antibodies causing resistance to replacement clotting factors.
Pharma Sources Insight January 2025
